Search Results - Michael Xu
- Showing 1 - 3 results of 3
-
1
Efficacy and safety of visepegenatide as an add-on therapy to metformin in patients with type 2 diabetes: a randomised, double-blind, parallel, placebo-controlled, phase 3 studyRes... by Xiaoling Cai, Linong Ji, Mingxia Yuan, Jianhua Ma, Fang Bian, Sheli Li, Wuyan Pang, Shuang Yan, Huimin Zhou, Minghui Hou, Wenhui Li, Ying Jia, Li Liu, Ke Ding, Michael Xu
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Efficacy and safety of visepegenatide, a long-acting weekly GLP-1 receptor agonist as monotherapy in type 2 diabetes mellitus: a randomised, double-blind, parallel, placebo-control... by Xiang Yan, Jianhua Ma, Yan Liu, Xuhong Wang, Sheli Li, Shuang Yan, Zhaohui Mo, Yikun Zhu, Jingna Lin, Jie Liu, Ying Jia, Li Liu, Ke Ding, Michael Xu, Zhiguang Zhou
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
Bridging the Gap: Collaboration between a School of Pharmacy, Public Health, and Governmental Organizations to provide Clinical and Economic Services to Medicare Beneficiaries by Rajul Patel, Mary Anne Choi, Dorothy Fan, Vincent Man, Cathy Thao, Thanh Thai, Michaela Vachuska, Milana Vachuska, Michael Xu, Cynthia S. Valle-Oseguera, Carly A. Ranson, Christopher Pham, Edward L Rogan, Mark P Walberg, joseph A Woelfel
Published 2018Call Number: Loading…Connect to this object online.
Located: Loading…
Book